Quality-Adjusted Life Years Concept

subject area of

• Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)  Journal Articles
• A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly  Journal Articles
• A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada  Journal Articles
• A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care  Journal Articles
• A Randomized Clinical Trial of Lung Volume Reduction Surgery Versus Best Medical Care for Patients With Advanced Emphysema: A Two-Year Study From Canada  Journal Articles
• A Randomized Multicenter Trial to Evaluate Simple Utility Elicitation Techniques in Patients With Gastroesophageal Reflux Disease  Journal Articles
• A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis  Journal Articles
• A Second-Order Simulation Model of the Cost-Effectiveness of Managing Dyspepsia in the United States  Journal Articles
• A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics  Journal Articles
• A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer’s disease and their caregivers  Journal Articles
• A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.  Journal Articles
• A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).  Journal Articles
• A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results  Journal Articles
• A review of health utilities across conditions common in paediatric and adult populations  Journal Articles
• A systematic review of full economic evaluations of robotic-assisted surgery in thoracic and abdominopelvic procedures  Journal Articles
• A view from the bridge: agreement between the SF‐6D utility algorithm and the Health Utilities Index  Journal Articles
• Active Surveillance, Radiofrequency Ablation, or Cryoablation for the Nonsurgical Management of a Small Renal Mass: A Cost-Utility Analysis  Journal Articles
• Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters  Journal Articles
• Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019  Journal Articles
• Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019  Journal Articles
• Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Alternatives to the QALY measure for economic evaluations  Journal Articles
• An economic evaluation of early versus delayed operative treatment in patients with closed tibial shaft fractures  Journal Articles
• An instrument to assess quality of life in relation to nutrition: item generation, item reduction and initial validation  Journal Articles
• Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?  Journal Articles
• Analysis, Sample Size, and Power for Estimating Incremental Net Health Benefit from Clinical Trial Data  Journal Articles
• Analyzing Oncology Clinical Trial Data Using the Q-TWiST Method: Clinical Importance and Sources for Health State Preference Data*  Journal Articles
• Antiviral Agents for Influenza  Journal Articles
• Are quality of life, patient preferences, and costs realistic outcomes for clinical trials?  Journal Articles
• As Good As It Gets but Good Enough for Which Applications?  Journal Articles
• Assessing Differences in Utility Scores: A Comparison of Four Widely Used Preference-Based Instruments  Journal Articles
• Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019  Journal Articles
• Assessing the impact of a home-based stroke rehabilitation programme: a cost-effectiveness study  Journal Articles
• Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients  Journal Articles
• Assessment of Utilities and Health-Related Quality of Life in Patients With Chronic Liver Disease  Journal Articles
• Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness  Journal Articles
• Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Journal Articles
• Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices  Journal Articles
• Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017  Journal Articles
• Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices  Journal Articles
• Calculating Ex-ante Utilities From the Modified Japanese Orthopedic Association Score  Journal Articles
• Calculating Utilities From the Spine Oncology Study Group Outcomes Questionnaire  Journal Articles
• Can the value choices in DALYs influence global priority-setting?  Journal Articles
• Canada's Population Health Model (POHEM)  Journal Articles
• Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.  Journal Articles
• Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Journal Articles
• Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019  Journal Articles
• Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?  Journal Articles
• Choices of Methodology in Pharmacoeconomic Studies  Journal Articles
• Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care  Journal Articles
• Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model  Journal Articles
• Clinically Important Differences in Q-TWIST – One Twist too Many?  Journal Articles
• Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions”  Journal Articles
• Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions”  Journal Articles
• Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?  Journal Articles
• Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease  Journal Articles
• Comparison of the Deep Inferior Epigastric Perforator Flap and Free Transverse Rectus Abdominis Myocutaneous Flap in Postmastectomy Reconstruction: A Cost-Effectiveness Analysis  Journal Articles
• Considering quality of life for children with cancer: a systematic review of patient-reported outcome measures and the development of a conceptual model  Journal Articles
• Cost Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Spain  Journal Articles
• Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer  Journal Articles
• Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy  Journal Articles
• Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma  Journal Articles
• Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis  Journal Articles
• Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy  Journal Articles
• Cost Effectiveness of a Survivorship Care Plan for Breast Cancer Survivors  Journal Articles
• Cost effectiveness analysis of population-based serology screening and ¹³C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model  Journal Articles
• Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis  Journal Articles
• Cost-Benefit Analyses in the Health-Care Literature: Don't Judge a Study by Its Label  Journal Articles
• Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer  Journal Articles
• Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada  Journal Articles
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Journal Articles
• Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn  Journal Articles
• Cost-Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Italy  Journal Articles
• Cost-Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in the United Kingdom  Journal Articles
• Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data  Journal Articles
• Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis  Journal Articles
• Cost-Effectiveness of Semaglutide in Patients With Obesity and Cardiovascular Disease.  Journal Articles
• Cost-Utility Analysis in Depression: The McSad Utility Measure for Depression Health States  Journal Articles
• Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study  Journal Articles
• Cost-Utility Analysis of Low-Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack.  Journal Articles
• Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation  Journal Articles
• Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese  Journal Articles
• Cost-effectiveness analysis of a community paramedicine programme for low-income seniors living in subsidised housing: the community paramedicine at clinic programme (CP@clinic)  Journal Articles
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Journal Articles
• Cost-effectiveness analysis of health tapestry, a complex primary care program for older adults: a post-hoc analysis  Journal Articles
• Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada  Journal Articles
• Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective  Journal Articles
• Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective  Journal Articles
• Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada  Journal Articles
• Cost-effectiveness analysis of the Geriatric Fracture Center (GFC) concept: a prospective multicentre cohort study  Journal Articles
• Cost-effectiveness and economic impact of the KineSpring® Knee Implant System in the treatment for knee osteoarthritis  Journal Articles
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Journal Articles
• Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis  Journal Articles
• Cost-effectiveness of Lung Cancer Screening in Canada  Journal Articles
• Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China  Journal Articles
• Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records  Journal Articles
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial  Journal Articles
• Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada  Journal Articles
• Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada  Journal Articles
• Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands  Journal Articles
• Cost-effectiveness of reducing wait times for cataract surgery in Ontario  Journal Articles
• Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada  Journal Articles
• Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada.  Journal Articles
• Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective  Journal Articles
• Cost-utility analysis of a multispecialty interprofessional team dementia care model in Ontario, Canada  Journal Articles
• Cost-utility and cost-benefit analyses  Journal Articles
• Cost-utility of nelarabine for the first-line treatment of newly diagnosed pediatric T-cell acute lymphoblastic leukemia in Canada.  Conferences
• Cost-utility of public health nurse-delivered group cognitive behavioural therapy for postpartum depression.  Journal Articles
• Cost‐Effectiveness Analysis of Zinc Supplementation for Treatment of Acute Diarrhea in Children Younger Than 5 Years in Colombia  Journal Articles
• Cost‐effectiveness of a collaborative dementia care management—Results of a cluster‐randomized controlled trial  Journal Articles
• Cost‐effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long‐term model based on the cure trial  Journal Articles
• Cost‐effectiveness of the endoscopic versus microscopic approach for pituitary adenoma resection  Journal Articles
• Cost‐utility analysis comparing free and pedicled TRAM flap for breast reconstruction  Journal Articles
• Cost–Utility of Group Versus Individual Acupuncture for Cancer-Related Pain Using Quality-Adjusted Life Years in a Noninferiority Trial  Journal Articles
• Creating a Multiply Imputed Value Set for the EQ-5D-5L in Canada: State-Level Misspecification Terms Are Needed to Characterize Parameter Uncertainty Correctly  Journal Articles
• DEALE-ing with Lung Cancer and Heart Failure  Journal Articles
• Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada  Journal Articles
• Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer  Journal Articles
• Deficits in preference-based health-related quality of life after complications associated with tibial fracture  Journal Articles
• Describing the resource utilisation and costs associated withvertebral fractures: the Build Better Bones with Exercise (B3E) Pilot Trial  Journal Articles
• Design and rationale for a pragmatic cluster randomized trial of the Cardiovascular Health Awareness Program (CHAP) for social housing residents in Ontario and Quebec, Canada  Journal Articles
• Determinants of cost-effectiveness results of biological therapies for severe asthma: a systematic methodological assessment.  Journal Articles
• Determing the threshold of acceptability of an ICER when natural health units are used.  Journal Articles
• Development of the Health Awareness and Behaviour Tool (HABiT): reliability and suitability for a Canadian older adult population  Journal Articles
• Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation  Journal Articles
• Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010  Journal Articles
• Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017  Journal Articles
• Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses  Journal Articles
• Double discounting of QALYs  Journal Articles
• Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial  Journal Articles
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Journal Articles
• Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost–Utility Analysis  Journal Articles
• Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year  Journal Articles
• Economic Evaluation of Early Psychosis Interventions From A Canadian Perspective  Journal Articles
• Economic Evaluation of Palliative Care Interventions: A Review of the Evolution of Methods From 2011 to 2019  Journal Articles
• Economic evaluation and health-related quality of life  Conferences
• Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India  Journal Articles
• Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario  Journal Articles
• Economic evaluation of hematopoietic stem cell transplantation  Journal Articles
• Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes  Journal Articles
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Journal Articles
• Economic evaluation of the “paramedics and palliative care: bringing vital services to Canadians” program compared to the status quo  Journal Articles
• Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood  Journal Articles
• Economic evaluation of treatments for cancer in childhood  Journal Articles
• Economics of Preoperative Radiotherapy With Total Mesorectal Excision: What Can We Learn From the Dutch Experience?  Journal Articles
• Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure  Journal Articles
• Effect of preventive primary care outreach on health related quality of life among older adults at risk of functional decline: randomised controlled trial  Journal Articles
• Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals  Journal Articles
• Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP)  Journal Articles
• Epidemiological Trends of Urolithiasis at the Global, Regional, and National Levels: A Population-Based Study.  Journal Articles
• Epidemiology of injuries from fire, heat and hot substances: global, regional and national morbidity and mortality estimates from the Global Burden of Disease 2017 study  Journal Articles
• Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery.  Journal Articles
• Establishing disability weights for congenital pediatric surgical conditions: a multi-modal approach  Journal Articles
• Establishing the minimal number of items for a responsive, valid, health-related quality of life instrument  Journal Articles
• Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015  Journal Articles
• Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019  Journal Articles
• Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study  Journal Articles
• Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis  Journal Articles
• Examination of psychological risk factors for chronic pain following cardiac surgery: protocol for a prospective observational study  Journal Articles
• Factors determining utility measured with the EQ-5D in patients with atrial fibrillation  Journal Articles
• Five preference-based indexes in cataract and heart failure patients were not equally responsive to change  Journal Articles
• Fragility Fractures: A Global Problem?  Journal Articles
• Gambling with Gastroesophageal Reflux Disease: Should We Worry about the QALY?  Journal Articles
• Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12  Journal Articles
• Global Burden of Cardiovascular Diseases and Risks, 1990-2022  Journal Articles
• Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010  Journal Articles
• Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010  Journal Articles
• Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021  Journal Articles
• Global burden of alcoholic liver diseases  Journal Articles
• Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017  Journal Articles
• Global trends of hand and wrist trauma: a systematic analysis of fracture and digit amputation using the Global Burden of Disease 2017 Study  Journal Articles
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016  Journal Articles
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017  Journal Articles
• Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019  Journal Articles
• Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Journal Articles
• Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Journal Articles
• Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021  Journal Articles
• Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021  Journal Articles
• Global, regional, and national burden of household air pollution, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.  Journal Articles
• Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Journal Articles
• Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.  Journal Articles
• Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Journal Articles
• Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015  Journal Articles
• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Journal Articles
• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition  Journal Articles
• Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015  Journal Articles
• Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Journal Articles
• Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Journal Articles
• Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015  Journal Articles
• Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis  Journal Articles
• HYEs: Do We Need Them and Can They Fulfil the Promise?  Journal Articles
• Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index  Journal Articles
• Health Technology Reassessment: Addressing Uncertainty in Economic Evaluations of Oncology Drugs at Time of Reimbursement Using Long-Term Clinical Trial Data  Journal Articles
• Health Utilities Index Mark 3 scores for major chronic conditions: Population norms for Canada based on the 2013 and 2014 Canadian Community Health Survey.  Journal Articles
• Health Utility Scores in Alzheimer’s Disease: Differences Based on Calculation With American and Canadian Preference Weights  Journal Articles
• Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease  Journal Articles
• Health trends in Canada 1990–2019: An analysis for the Global Burden of Disease Study  Journal Articles
• Health years equivalents as a measurement of preferences for dental interventions.  Journal Articles
• Health-Related Quality of Life and Cost-Effectiveness Components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design  Journal Articles
• Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review*  Journal Articles
• Health‐related quality of life among children with acute lymphoblastic leukemia  Journal Articles
• Health‐related quality of life in adolescents and young adults with cancer – Including a focus on economic evaluation  Journal Articles
• How to use the results of an economic evaluation  Journal Articles
• Identifying determinants of quality of life of children with cancer and childhood cancer survivors: a systematic review  Journal Articles
• Impact of stent diameter and length on in‐stent restenosis after DES vs BMS implantation in patients needing large coronary stents—A clinical and health‐economic evaluation  Journal Articles
• Impact of the 1997 Canadian Guidelines on the Conduct of Canadian-Based Economic Evaluations in the Published Literature  Journal Articles
• Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate  Journal Articles
• Incorporating Mortality in Health Utility Measures  Journal Articles
• Incremental cost-effectiveness ratios (ICERs): The silence of the lambda  Journal Articles
• Incremental net benefit in randomized clinical trials with quality‐adjusted survival  Journal Articles
• Industry sponsorship bias in cost effectiveness analysis: registry based analysis  Journal Articles
• Integrating Mortality and Morbidity Outcomes  Journal Articles
• Internal validation of models with several interventions  Journal Articles
• Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial  Conferences
• Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Journal Articles
• Is bad living better than good death? Impact of demographic and cultural factors on health state preference  Journal Articles
• Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials  Journal Articles
• Is there a kink in consumers' threshold value for cost‐effectiveness in health care?  Journal Articles
• Lateral extra-articular tenodesis may be more cost-effective than independent anterolateral ligament reconstruction: A systematic review and economic analysis  Journal Articles
• Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation  Journal Articles
• Long-term follow-up of survivors of acute lung injury: Lack of effect of a ventilation strategy to prevent barotrauma  Journal Articles
• Low-intensity pulsed ultrasound for treatment of tibial fractures  Journal Articles
• Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415  Conferences
• Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415  Journal Articles
• Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016  Journal Articles
• Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015  Journal Articles
• Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients  Journal Articles
• Methodological considerations in injury burden of disease studies across Europe: a systematic literature review  Journal Articles
• Methodology and measurement properties of health-related quality of life instruments: A prospective study of patients undergoing breast reduction surgery  Journal Articles
• Modelling the Cost Effectiveness of Antidepressant Treatment in Primary Care  Journal Articles
• Money matters: what to look for in an economic analysis  Journal Articles
• Multiattribute Utility Function for a Comprehensive Health Status Classification System  Journal Articles
• Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System  Journal Articles
• NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales  Journal Articles
• National burden of rheumatoid arthritis in Canada, 1990–2019: findings from the Global Burden of Disease Study 2019 – a GBD collaborator-led study  Journal Articles
• Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes  Journal Articles
• Nonwage Losses Associated With Occupational Injury Among Health Care Workers  Journal Articles
• On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales  Journal Articles
• On the margins of health economics: a response to ‘resolving NICE’S nasty dilemma’  Journal Articles
• Oral conditions contribute to a small proportion of the quality-adjusted life expectancy loss at age 20 years  Journal Articles
• Osteochondroplasty with or without labral repair is more cost-effective than arthroscopic lavage with or without labral repair for treatment of young adults with femoroacetabular impingement: A cost-utility analysis based on data from a randomized controlled trial.  Journal Articles
• Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets  Journal Articles
• Patient Preferences and the Measurement of Utilities in the Evaluation of Dental Technologies  Journal Articles
• Patient values and preferences on valve replacement for aortic stenosis: a systematic review  Journal Articles
• Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection.  Journal Articles
• Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation  Journal Articles
• Photodynamic Therapy for Barrett’s Esophagus with High-Grade Dysplasia: A Cost-Effectiveness Analysis  Journal Articles
• Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke  Journal Articles
• Preference based measurements in dentistry: a review of the literature and recommendations for research.  Journal Articles
• Preferences for health outcomes and cost-utility analysis.  Journal Articles
• Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Journal Articles
• Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group  Journal Articles
• Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial  Journal Articles
• QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique  Journal Articles
• QALYs and HYEs Spotting the differences  Journal Articles
• QALYs: The Basics  Journal Articles
• Quality-Adjusted Life-Year as a Surgical Outcome Measure: A Primer for Plastic Surgeons  Journal Articles
• Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey  Journal Articles
• Quantifying the Disability from Congenital Anomalies Averted Through Pediatric Surgery: A Cross‐Sectional Comparison of a Pediatric Surgical Unit in Kenya and Canada  Journal Articles
• Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach  Journal Articles
• Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation  Journal Articles
• Regression methods for cost-effectiveness analysis with censored data  Journal Articles
• Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life  Journal Articles
• Responsiveness of generic health-related quality of life measures in stroke  Journal Articles
• Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer  Journal Articles
• Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura  Journal Articles
• Resurrecting Multiattribute Utility Function: Developing a Value Set for Health Utility for Glaucoma  Journal Articles
• Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data  Journal Articles
• Screening and Prevention of Venous Thromboembolism in Critically Ill Patients  Journal Articles
• Semi‐parametric regression models for cost‐effectiveness analysis: improving the efficiency of estimation from censored data  Journal Articles
• Social factors in frequent callers: a description of isolation, poverty and quality of life in those calling emergency medical services frequently  Journal Articles
• Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019  Journal Articles
• Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019  Journal Articles
• Sponsorship bias in oncology cost effectiveness analysis  Journal Articles
• Systematic methodological review of health state values in glaucoma cost-utility analyses  Journal Articles
• Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding  Journal Articles
• Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding  Journal Articles
• Systematic reviews, economic evaluations, and practice guidelines: can research synthesis help us care for the critically ill?  Journal Articles
• Tamoxifen for Breast Cancer Risk Reduction  Journal Articles
• The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019  Journal Articles
• The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial  Journal Articles
• The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories  Journal Articles
• The Health Utilities Index (HUI): concepts, measurement properties and applications.  Journal Articles
• The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective Study  Journal Articles
• The NICE Reference Case Requirement  Journal Articles
• The National Lung Screening Trial: Overview and Study Design  Journal Articles
• The PROMIS of QALYs  Journal Articles
• The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer  Journal Articles
• The Utility of Hand Transplantation in Hand Amputee Patients  Journal Articles
• The additive utility assumption of the QALY model revisited  Journal Articles
• The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold  Journal Articles
• The burden of disease in older people and implications for health policy and practice  Journal Articles
• The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study  Journal Articles
• The burden of waiting: DALYs accrued from delayed access to pediatric surgery in Kenya and Canada  Conferences
• The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis.  Journal Articles
• The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic  Journal Articles
• The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes  Journal Articles
• The economic burden of child marriage in Nigeria.  Journal Articles
• The economic burden of lung cancer and mesothelioma due to occupational and para-occupational asbestos exposure  Journal Articles
• The feasibility and responsiveness of the health utilities index in patients with early-stage breast cancer: A prospective longitudinal study  Journal Articles
• The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019  Journal Articles
• The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Journal Articles
• The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Journal Articles
• The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017  Journal Articles
• The health economics of Helicobacter pylori infection  Journal Articles
• The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach  Journal Articles
• The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices  Journal Articles
• The ‘NICE’ Approach to Technology Assessment: An Economics Perspective  Journal Articles
• Thrombosis: A major contributor to global disease burden  Journal Articles
• Thrombosis: A major contributor to global disease burden  Journal Articles
• Time-Specific Differences in Stated Preferences for Health in the United States  Journal Articles
• To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.  Journal Articles
• Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)  Journal Articles
• Transforming Latent Utilities to Health Utilities: East Does Not Meet West  Journal Articles
• Translation and cultural adaptation of Health Utilities Index (HUI) Mark 2 (HUI2) and Mark 3 (HUI3) with application to survivors of childhood cancer in Brazil  Journal Articles
• Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments  Journal Articles
• Understanding Costs and Cost-Effectiveness in Critical Care  Journal Articles
• Unfinished Symphony: A Tribute to the Life and Career of Bernie O’Brien (1959–2004)  Journal Articles
• United States Valuation of EQ-5D-5L Health States Using an International Protocol  Journal Articles
• Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness Analysis  Journal Articles
• Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study  Journal Articles
• Use of Decision Analysis and Economic Evaluation in Upper Extremity Surgery: A Systematic Review.  Journal Articles
• Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index  Journal Articles
• Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group  Journal Articles
• Using Linear Equating to Map PROMIS® Global Health Items and the PROMIS-29 V2.0 Profile Measure to the Health Utilities Index Mark 3  Journal Articles
• Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease  Journal Articles
• Using existing data to identify candidate items for a health state classification system in multiple sclerosis  Journal Articles
• Valuing Outcomes in Health Care  Journal Articles
• Valuing the benefits and costs of health care programmes: where's the ‘extra’ in extra-welfarism?  Journal Articles
• Visual analog scales: do they have a role in the measurement of preferences for health states?  Journal Articles
• What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks  Journal Articles
• Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.  Journal Articles
• Who Benefits Most from Collaborative Dementia Care from a Patient and Payer Perspective? A Subgroup Cost-Effectiveness Analysis  Journal Articles
• Whose priorities count? Comparison of community‐identified health problems and Burden‐of‐Disease‐assessed health priorities in a district in Uganda  Journal Articles
• Willingness to Pay and the Valuation of Programmes for the Prevention and Control of Influenza  Journal Articles
• Willingness to pay for dentin regeneration in a sample of dentate adults  Journal Articles
• Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.  Journal Articles
• Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.  Journal Articles
• World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010  Journal Articles
• Worldwide Prevalence and Disability From Mental Disorders Across Childhood and Adolescence  Journal Articles
• Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism  Journal Articles
• Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010  Journal Articles
• [Economic evaluation of bevacizumab versus ranibizumab in neovascular age-related macular degeneration].  Journal Articles